Provigil, Modafinil
Provigil, Modafinil Newswire

Provigil, Modafinil Newswire

Comprehensive Real-Time News Feed for Provigil, Modafinil (generic).

Results 1 - 20 of 72 in Provigil, Modafinil (generic)

  1. SaveRxCanada.to Features Generic Provigil in their Canadian Pharmacy CatalogRead the original story w/Photo

    Apr 11, 2015 | 24-7 Press Release

    SaveRxCanada.to , a trusted and established online pharmacy intermediary features Provigil as their International Generics product in the spotlight. Provigil is a prescription medicine used to improve wakefulness in adults who experience excessive sleepiness due to one of the following diagnosed sleep disorders: obstructive sleep apnea , shift work sleep disorder, also known as shift work disorder, or narcolepsy.

    Comment?

  2. NationDrugs.to Highlights the Benefits and Side Effects of ProvigilRead the original story w/Photo

    Mar 28, 2015 | 24-7 Press Release

    NationDrugs.to the premier Canadian pharmacy intermediary since 2002, highlights the benefits and side effects of Provigil . The people fighting excessive sleep disorders and problems like narcolepsy, sleep apnea can find a solution in Provigil, the medicine that induces wakefulness and helps people stay alert in their day to day activities.

    Comment?

  3. NationDrugs.to Discusses the Difference between Provigil and NuvigilRead the original story w/Photo

    Mar 27, 2015 | 24-7 Press Release

    CANADA, March 28, 2015 /24-7PressRelease/ -- NationDrugs.to the premier online pharmacy intermediary since 2002, discusses the difference between two popular medications Provigil and Nuvigil used to treat narcolepsy, obstructive sleep apnea, or other serious sleep problems. Provigil and Nuvigil are closely related smart drugs used to increase energy levels and improve focus and alertness.

    Comment?

  4. NationDrugs.to Warns Buying Provigil Online Without a Prescription is a ScamRead the original story w/Photo

    Mar 25, 2015 | 24-7 Press Release

    Nationdrugs.to, a Canadian pharmacy intermediary for over 13 years highlights the dangers of buying Provigil online without a prescription. CANADA, March 26, 2015 /24-7PressRelease/ -- NationDrugs.to the premier Canadian pharmacy intermediary since 2002, celebrating over 13 years of business excellence in Canada warns consumers of the dangers of buying Provigil online without a prescription.

    Comment?

  5. Generic Provigil Shipping Promotion Announced by Canada Online Pharmacy Intermediary NationDrugs.toRead the original story w/Photo

    Mar 23, 2015 | 24-7 Press Release

    NationDrugs.to announces that generic Provigil is now available through its International Generics Program promotion. Provigil is a medication that promotes wakefulness and is used to treat excessive sleepiness caused by sleep apnea, narcolepsy, or shift work sleep disorder.

    Comment?

  6. Can anti-aging smart drugs boost your brainpower?Read the original story w/Photo

    Tuesday Jun 16 | Consumer Reports

    Age may bring wisdom, but we all want to feel youthful in mind and body. Our quest to keep age-related physical and cognitive changes at bay- has created a huge anti-aging industry-reportedly worth about $292 billion worldwide this year-one that includes drugs to boost cognition.

    Comment?

  7. Just How Smart Are 'Smart Drugs' For Healthy Users?Read the original story w/Photo

    Tuesday Jun 2 | PsychCentral

    Experts are highlighting the benefits and potential dangers of cognitive-enhancing or "smart drugs," intended to treat psychological disorders but increasingly used by healthy people to gain an edge in performance. These include methylphenidate and modafinil .

    Comment?

  8. Teva fined $1.2bn in pay-for-delay caseRead the original story

    Monday Jun 1 | Chemistry World

    Israeli firm Teva has reached a settlement with the US Federal Trade Commission over allegations of cutting illegal deals with generic drugmakers to stifle competition for sleep disorder drug Provigil . The company will pay $1.2 billion to the US Treasury, most of which will go towards compensation for buyers who overpaid for the drug as a result of the deals.

    Comment?

  9. Teva agrees to pay FTC $1.2 bn in Cephalon antitrust caseRead the original story w/Photo

    Sunday May 31 | Big News Network.com

    Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news. With a traditional newspaper format, more than 100 sites were established each with a newspaper-type name to cover the highest-ranked regions, countries, cities and states.

    Comment?

  10. FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains RelinquishedRead the original story

    May 28, 2015 | Holtville Tribune

    The Federal Trade Commission has reached a settlement resolving the Commission's antitrust suit charging Cephalon, Inc. with illegally blocking generic competition to its blockbuster sleep-disorder drug Provigil. The settlement ensures that Teva Pharmaceutical Industries, Ltd., which acquired Cephalon in 2012, will make a total of $1.2 billion available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon's illegal conduct.

    Comment?

  11. Teva reaches $1.2B settlement with the FTCRead the original story w/Photo

    May 28, 2015 | Business Journal

    Teva Pharmaceuticals Industries has agreed to pay $1.2 billion to settle charges that Chester County-based Cephalon, which Teva acquired in 2011, illegally blocked the launch of generic versions of its sleep disorder drug Provigil. The settlement reached with the Federal Trade Commission is part of the agency's ongoing efforts to crackdown on "pay-for-delay" deals, under which the makers of brand name prescription drug products allegedly work out agreements with generic drug pharmaceuticals to delay the launch of competing products.

    Comment?

  12. Teva pays $1.2B in antitrust drug settlementRead the original story w/Photo

    May 28, 2015 | USA Today

    Teva Pharmaceutical Industries has agreed to a $1.2 billion settlement that resolve federal anti-competition allegations over sales of a popular sleep-disorder drug, the Federal Trade Commission said Thursday. Teva agrees to $1.2B FTC anti-trust settlement Teva Pharmaceutical Industries has agreed to a $1.2 billion settlement that resolve federal anti-competition allegations over sales of a popular sleep-disorder drug, the Federal Trade Commission said Thursday.

    Comment?

  13. FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in ...Read the original story

    May 28, 2015 | Federal Trade Commission

    FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics Note: A press conference with FTC Chairwoman Edith Ramirez and Bureau of Competition Director Deborah Feinstein was held at the FTC on May 28, 2015, at 11 a.m. ET. Chairwoman Ramirez and FTC staff took questions from the media about the case.

    Comment?

  14. Teva Settles Cephalon Case with FTC for $1.2BRead the original story

    May 28, 2015 | Courthouse News Service

    Teva Pharmaceuticals will pay $1.2 billion to settle Federal Trade Commission charges that it unlawfully stymied generic competition to is sleep-disorder drug Provigil. The settlement announced Thursday potentially brings to an end the agency's long-running litigation over the drug, which was filed against Cephalon, Provigil's developer, in May 2008.

    Comment?

  15. IstockSilicon Valley's Eating Up Super RitalinNootropics, the new...Read the original story w/Photo

    May 27, 2015 | The Daily Beast

    Nootropics, the new staple 'brain enhancers' in Silicon Valley that purport to increase productivity and perception, exist in an unregulated legal gray area in the U.S. In Colombia, you can pick up even the shadiest kinds over the counter. I did just that.

    Comment?

  16. Sebastian Shakespeare: Bamber challenged over sale of aunt's treasuresRead the original story w/Photo

    May 8, 2015 | Daily Mail

    When ex-University Challenge host Bamber Gascoigne unexpectedly inherited West Horsley Place in Surrey, he pledged to rescue the crumbling Grade I-listed home from ruin. But while the country house fraternity was delighted with the Old Etonian quizmaster's largesse - he could have just flogged the historic home of his great aunt Mary, Duchess of Roxburghe - I hear that his project has been met with some resistance.

    Comment?

  17. 6 Signs You're Suffering From Shift Work DisorderRead the original story

    Apr 23, 2015 | Lifehack.org

    If you are in healthcare, IT, security, manufacturing or in the hospitality or entertainment field, you may have to work shifts. You are just one of the 15 million Americans who do so.

    Comment?

  18. Teva to Pay $512M to Settle Antitrust ClaimsRead the original story

    Apr 22, 2015 | Courthouse News Service

    Teva Pharmaceuticals agreed to pay $512 million to settle claims its Cephalon subsidiary bought out prospective generic drug makers to maintain the market dominance of its wakefulness drug, Provigil. The settlement is the largest ever to be paid to drug wholesalers and retailers over the alleged purposeful delaying of generic drugs, the Justice Department said.

    Comment?

  19. Teva to Pay $512 Million to Resolve Provigil-Delay LawsuitRead the original story

    Apr 20, 2015 | The Washington Post

    Cephalon Inc., which Teva acquired in 2011, agreed to settle the antitrust case after a federal judge in Philadelphia refused this year to throw out purchasers' claims that agreements between drugmakers to postpone release of generic medicines amount to anticompetitive behavior. The settlement is the largest in a case over attempts to slow the pace of less expensive generic drugs coming to the U.S. market, attorneys for Provigil buyers said in court filings.

    Comment?

  20. Teva to pay $512M to resolve Provigil-delay lawsuitRead the original story w/Photo

    Apr 20, 2015 | Philly.com

    Teva Pharmaceutical Industries Ltd. will pay $512 million to resolve a class-action lawsuit that accused the drugmaker of conspiring to delay sales of generic versions of its sleep-disorder medicine Provigil, ending almost a decade of litigation. Cephalon Inc., which Teva acquired in 2011, agreed to settle the antitrust case after a federal judge in Philadelphia refused this year to throw out purchasers' claims that agreements between drugmakers to postpone release of generic medicines amount to anticompetitive behavior.

    Comment?